Logo-apb
Original Research

1. Aberrant Phenotype in Iranian Patients with Acute Myeloid Leukemia
Mehdi Jahedi, Karim Shamsasenjan, Zohreh Sanaat, Mohammad Reza Aliparasti, Shohreh Almasi, Mozhdeh Mohamadian, Babak Nejati, Amir Kamalifar, Ali Akbar Movassaghpour*
Adv Pharm Bull. 2014;4(1): 43-47. doi: 10.5681/apb.2014.007
PMCID: PMC3885367     PMID: 24409408     Scopus ID: 84892453971    
Article
PDF
XML
Cited By:
5
2
Original Research

2. ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines
Hassan Dariushnejad, Nosratallah Zarghami*, Mohammad Rahmati, Samaneh Ghasemali, Zohreh Sadeghi, Zahra Davoudi, Hossein Jafari Tekab, Masoud Gandomkar Ghalhar
Adv Pharm Bull. 2014;4(2): 185-189. doi: 10.5681/apb.2014.027
PMCID: PMC3915819     PMID: 24511483     Scopus ID: 84892458525    
Article
PDF
XML
Cited By:
7
4
Research Article

3. WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy
Hossein Mehralizadeh ORCID, Mohammad Reza Aliparasti, Mehdi Talebi, Shabnam Salekzamani, Shohreh Almasi, Morteza Raeisi, Mehdi Yousefi, AliAkbar Movassaghpour* ORCID
Adv Pharm Bull. 2021;11(1): 197-203. doi: 10.34172/apb.2021.021
PMCID: PMC7961226     PMID: 33747867     Scopus ID: 85096950936    
Article
PDF
Full Text
XML
Cited By:
1
0
3
Research Article

4. The Effect of Telomerase Inhibition on NK Cell Activity in Acute Myeloid Leukemia
Khadijeh Dizaji Asl ORCID, Ali Rafat ORCID, Ali Akbar Movassaghpour ORCID, Hojjatollah Nozad Charoudeh ORCID, Hamid Tayefi Nasrabadi* ORCID
Adv Pharm Bull. 2023;13(1): 170-175. doi: 10.34172/apb.2023.018
PMCID: PMC9871272     PMID: 36721807    
Article
PDF
Full Text
XML
Cited By:
0
0

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by